Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tradipitant in treatment-resistant pruritus associated with atopic dermatitis
NCT02004041Phase 2Completed
- Sponsor
- Vanda Pharmaceuticals Inc.
- Start
- Dec 2013
- Primary completion
- Feb 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tradipitant in atopic dermatitis (AD), sponsored by Vanda Pharmaceuticals Inc.. Started Dec 2013; status: completed.
02
Drugs
tradipitant
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT02004041.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02004041.